13 Ray Dalio Royalty Pharma plc Trades
Ray Dalio acquired 21.1 Thousand Royalty Pharma plc shares worth $592 Thousand. That's 0.00% of their equity portfolio (672nd largest holding). The first Royalty Pharma plc trade was made in Q4 2020. Since then Ray Dalio bought shares six more times and sold shares on six occasions. The investor's estimated purchase price is $748 Thousand, resulting in a loss of 21%.
Avg closing price
Price range
Sold 89.1% shares (-172 Thousand shares)
Q4 2023
Avg closing price
$27.48
Price range
$26.21
-
$29.22
Increased shares by 71.5% (+80.5 Thousand shares)
Q3 2023
Avg closing price
$29.70
Price range
$26.26
-
$31.38
Increased shares by 236.9% (+79.2 Thousand shares)
Q2 2023
Avg closing price
$33.87
Price range
$29.60
-
$36.56
Sold 14.5% shares (-5.66 Thousand shares)
Q1 2023
Avg closing price
$37.08
Price range
$32.77
-
$39.40
Sold 36.8% shares (-22.8 Thousand shares)
Q4 2022
Avg closing price
$41.74
Price range
$39.17
-
$44.04
Increased shares by 1065.0% (+56.5 Thousand shares)
Q3 2022
Avg closing price
$42.71
Price range
$39.88
-
$44.65
Sold 86.9% shares (-35.2 Thousand shares)
Q2 2022
Avg closing price
$41.01
Price range
$37.53
-
$44.22
Increased shares by 604.4% (+34.7 Thousand shares)
Q1 2022
Avg closing price
$39.27
Price range
$37.46
-
$42.44
New holding (+5.75 Thousand shares)
Q4 2021
Avg closing price
$38.85
Price range
$35.17
-
$42.48
Sold -18.3 Thousand shares
Q3 2021
Avg closing price
$38.86
Price range
$36.14
-
$42.24
New holding (+18.3 Thousand shares)
Q2 2021
Avg closing price
$42.54
Price range
$39.85
-
$46.63
Sold -13.5 Thousand shares
Q1 2021
Avg closing price
$47.41
Price range
$42.34
-
$52.82
New holding (+13.5 Thousand shares)
Q4 2020
Avg closing price
$42.43
Price range
$36.12
-
$50.05
